NSE/PVRINOX

PVRINOXPVR INOX Ltd

Media · NSE

₹937.65-1.39%

52-wk low52-WEEK RANGE52-wk high

₹869.5+7.8% from low ·-24.4% from high₹1,241

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

PVRINOX-47.91% · 1Y

Range high ₹1,925.45Range low ₹830Latest ₹937.65Powered by TradingView · live NSE data

MediaSmallcap

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite33/100

Performance

—

Not enough price history to score.

Valuation

Medium

Valuation close to the sector median.

· P/E 430.9 close to sector median 430.9

Growth

Medium

Steady but not standout growth.

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeD(35/100)

Durability

27/100

Durability concerns flagged across multiple health inputs.

Show 3 drivers

Piotroski F-score3/8 (38pt)
Altman Z" score-0.42 (0pt)
Debt/Equity1.05 (49pt)

Valuation

50/100

Trading at a premium — growth must keep delivering to justify.

Show 3 drivers

P/E vs sector (430.9 / 430.9)100% (60pt)
P/B1.28 (40pt)
EV/EBITDA14.2 (40pt)

Momentum

29/100

Negative momentum — trend and technicals stacked bearish.

Show 4 drivers

DMA-trend alignmentstrong down (0pt)
RSI (14)42.2 (35pt)
Price vs 200-DMA-10.6% (39pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)430.93

OVERVALUED

CheapestP/E 430.9 at 100th %ile — pricier than 100% of peers.Most expensive

P/B1.28

OVERVALUED

CheapestP/B 1.28 at 100th %ile of sector.Most expensive

EV/EBITDA14.22

FAIR

Monthly seasonality

Avg monthly return over 4 years · historical — not a forecast

Best: Aug +10.03% · Worst: Jan -8.51%

Jan

-8.5%

0% win

Feb

-7.1%

25% win

Mar

-2.9%

50% win

Apr

+0.8%

75% win

May

-0.8%

33% win

Jun

+1.5%

Monthly return distribution

Distribution of 41 monthly returns

Mean

-1.32%

Median

-2.96%

Std dev

7.96%

Best

+17.1%

Worst

-17.1%

% positive

41%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 1

Consistent top-line growth (63.1% 3Y CAGR)
Sustained revenue compounding is rare and hard to fake

WEAKNESSES · 3

Revenue contracting (-5.4% YoY)
Negative top-line growth is the hardest signal to overcome
Weak financial quality (Piotroski 3/8)
Score ≤3 signals multiple concerning accounting trends
Distress-zone Altman Z″ (-0.42)
Historically associated with elevated bankruptcy probability

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 1

Strong downtrend — DMA stack bearish
Price < 20 < 50 < 200 DMA: trend-followers are leaving

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

-1.4%

-1.2%

-3.7%

-8.1%

-14.7%

+6.1%

-16.5%

-17.3%

10Y

—

Fundamentals

VALUATION

Market cap

₹9,140 Cr

P/E (TTM)

430.9

P/E (fwd)

—

next 12m

P/B

1.28

EV/EBITDA

14.2

Book value

—

per share

PROFITABILITY · QUALITY

ROE

—

ROCE

—

Net margin

-4.8%

Op margin

—

Gross margin

—

D/E

1.05

GROWTH · MARKET

Rev YoY

-5.4%

Profit YoY

—

Div yield

—

Payout

—

52w change

—

Beta

—

Pros and cons

Auto-derived from ratios · not a buy/sell recommendation

PROS · 1

+3-year revenue CAGR of 63.1%Sustained multi-year growth — not a one-quarter flash

CONS · 2

−Very high absolute P/E (431x)At this multiple the market prices in several years of strong growth upfront — risk of correction if growth disappoints
−Revenue declining -5.4% YoYTop-line contraction — watch for cyclical vs structural

Sector-relative context

Media · 1 peers

P/E (TTM)

This stock

430.93

Sector median

430.93

Rank 1/1 (100th %ile)

ROE

This stock

—

Sector median

—

P/B

This stock

1.28

Sector median

1.28

Rank 1/1 (100th %ile)

Quality score · Piotroski F-score

3 / 8

Mixed quality — several weak points

✗Profitable (positive net income)· Most basic check — company makes money
✗Positive return on assets· Assets generate returns
✓Positive operating cash flow· Profits are backed by real cash, not accruals
✓Operating CF exceeds net profit· Healthy cash conversion — no aggressive revenue recognition
✓Long-term debt decreased YoY· Deleveraging — lower refinancing risk
✗ROA improved YoY· Getting more productive with the asset base
✗Operating margin expanded YoY· Pricing power or cost discipline
✗Asset turnover improved YoY

Forensic score · Altman Z″ (emerging markets)

Bankruptcy-risk predictor · 1995 Altman emerging-market revision

DISTRESS-0.42

Z″ = -0.42 — DISTRESS zone. Historical Altman-Z models have associated this range with elevated 2-year bankruptcy probability. Treat as a flag for deeper diligence, not a verdict.

Component	Ratio	Weight	Contribution
Working Capital / Total Assets (A)	0.100	×6.56	0.656
Retained Earnings / Total Assets (B)	-0.149	×3.26	-0.486
EBIT / Total Assets (C)	-0.069	×6.72	-0.464
Book Equity / Total Liabilities (D)	-0.123	×1.05	-0.130

Zones: Z″ ≥ 2.60 safe · 1.10–2.60 grey · < 1.10 distress. Working capital proxied from reported cash + 10% buffer (exact 'current assets − current liabilities' line not ingested). Treat as directional.

Quarterly results

Last 5 quarters · ₹ Cr (Screener.in-grade depth)

Metric	2024-Q3	2024-Q4	2025-Q1	2025-Q2	2025-Q4
Revenue	1,622	1,717	1,204	1,469	1,880
Operating profit	150	208	-32	89	305
OPM %	9.2%	12.1%	-2.7%	6.0%	16.2%
Interest	206	203

Annual P&L

Last 4 years · ₹ Cr · all line items

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Revenue	1,321	3,737	6,089	5,734
Operating profit	-505	276	605	263
OPM %	-38.3%	7.4%	9.9%	4.6%
Interest	471	542	766	788
Depreciation

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
PVRINOXTHIS PVR INOX Limited	₹937.65	-3.4%	9,140	430.9	1.28	—	1.05	-5.4%

ASK AXEL

Dig deeper into PVRINOX

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for PVRINOX — all in one sourced reply.

Ask free in chat

Run these tools on PVRINOX

Historical return →

"If I had bought PVRINOX in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on PVRINOX

Brokerage + charges →

All-in cost for trading PVRINOX

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Quarter	EPS estimate	EPS actual	Surprise %
-1q	9.03	13.31	+47.5%
-2q	11.27	10.73	-4.8%
-3q	-4.93	-5.51	-11.7%
-4q	-19.34	-12.73	+34.2%

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Equity capital	61	98	98	98
Reserves	-1,093	-1,427	-1,459	-1,738
Borrowings	5,196	8,052	8,304	7,775
Other liabilities	12	—	10	8
Total liabilities	7,326	16,477	16,820	16,262
Fixed assets	4,261	8,663	8,890	8,141
CWIP	64	346	293	118
Investments	1	1	1	10
Other assets	84	-0	107	77
Total assets	7,326	16,477	16,820	16,262

Metric	2022-FY	2023-FY	2024-FY	2025-FY
CF Operating	167	864	1,979	1,967
CF Investing	-3	-576	-627	-303
CF Financing	-217	-694	-1,293	-1,535
Net cash flow	-53	-169	60	130
Free cash flow	42	228	1,345	1,633

Metric	2025-FY	2024-FY	2023-FY	2022-FY
OPM %	4.6%	9.9%	7.4%	-38.3%
Net margin %	-4.9%	-0.5%	-9.0%	-37.0%
ROE %	18.6%	2.4%	28.4%	47.3%
ROCE %	6.3%	10.6%	6.1%	-5.0%
Debt / Equity	-4.74	-6.10	-6.06	-5.04
Interest coverage	0.5×	0.9×	0.6×	-0.4×
Revenue growth YoY	-5.8%	+62.9%	+183.0%	—
Profit growth YoY	-773.8%	+90.5%	+31.4%	—

PVRINOXPVR INOX Ltd

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Quarterly results

Annual P&L

Peer comparison · Media

Ask Axel about PVRINOX

Recent news

Dig deeper into PVRINOX

Run these tools on PVRINOX

Technical snapshot

Earnings history + surprises

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Quarterly results

Annual P&L

Stock scorecard

Balance sheet

Cash flow statement

Recent news

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Ratios

Peer comparison · Media